Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study.
Invest New Drugs. 2022 Apr;40(2):463. doi: 10.1007/s10637-021-01194-3.
Invest New Drugs. 2022.
PMID: 34731355
Free PMC article.
No abstract available.
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Thein KZ, Karp DD, Tsimberidou A, Gong J, Sulovic S, Shah J, Milton DR, Hong DS, Janku F, McQuinn L, Stephen BA, Colen R, Carter BW, Yap TA, Piha-Paul SA, Fu S, Meric-Bernstam F, Naing A.
Thein KZ, et al. Among authors: sulovic s.
Invest New Drugs. 2022 Apr;40(2):290-299. doi: 10.1007/s10637-021-01188-1. Epub 2021 Sep 25.
Invest New Drugs. 2022.
PMID: 34562230
Free PMC article.
Clinical Trial.
Item in Clipboard
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.
Thein KZ, Fu S, Janku F, Tsimberidou AM, Piha-Paul SA, Karp DD, Shah J, Milton DR, Gong J, Sulovic S, McQuinn L, Stephen BA, Colen RR, Carter BW, Meric-Bernstam F, Naing A.
Thein KZ, et al. Among authors: sulovic s.
J Immunother Precis Oncol. 2022 Feb 9;5(1):10-12. doi: 10.36401/JIPO-21-20. eCollection 2022 Feb.
J Immunother Precis Oncol. 2022.
PMID: 35663832
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite